436 related articles for article (PubMed ID: 30064520)
1. In vivo quantification of neurofibrillary tangles with [
Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
[TBL] [Abstract][Full Text] [Related]
2. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
3. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
[TBL] [Abstract][Full Text] [Related]
4. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
[TBL] [Abstract][Full Text] [Related]
7. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
8. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [
Guehl NJ; Wooten DW; Yokell DL; Moon SH; Dhaynaut M; Katz S; Moody KA; Gharagouzloo C; Kas A; Johnson KA; El Fakhri G; Normandin MD
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2099-2111. PubMed ID: 31332496
[TBL] [Abstract][Full Text] [Related]
10. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
11. Test-retest characteristic of [
Salinas C; Lohith TG; Purohit A; Struyk A; Sur C; Bennacef I; Beaver J; Martarello L
J Cereb Blood Flow Metab; 2020 Nov; 40(11):2179-2187. PubMed ID: 31711342
[TBL] [Abstract][Full Text] [Related]
12. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
13. Tau Imaging in Late Traumatic Brain Injury: A [
Vanderlinden G; Michiels L; Koole M; Lemmens R; Liessens D; Van Walleghem J; Depreitere B; Vandenbulcke M; Van Laere K
J Neurotrauma; 2024 Feb; 41(3-4):420-429. PubMed ID: 38038357
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry and efficacy of a tau PET tracer [
Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Safety Evaluation and Human Dosimetry of [
Koole M; Lohith TG; Valentine JL; Bennacef I; Declercq R; Reynders T; Riffel K; Celen S; Serdons K; Bormans G; Ferry-Martin S; Laroque P; Walji A; Hostetler ED; Briscoe RJ; de Hoon J; Sur C; Van Laere K; Struyk A
Mol Imaging Biol; 2020 Feb; 22(1):173-180. PubMed ID: 31111397
[TBL] [Abstract][Full Text] [Related]
17. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
[TBL] [Abstract][Full Text] [Related]
18. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
[TBL] [Abstract][Full Text] [Related]
19. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
20. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
